Trulieve Cannabis (TCNNF) Non Operating Income (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Non Operating Income of -$10.5 million in Q1 2026, down 1778.12% quarter-over-quarter from $626000.0 in Q4 2025, and up 19.19% on a YoY basis from -$8.8 million in Q1 2025.
Trulieve Cannabis (TCNNF) Non Operating Income (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Non Operating Income history runs 7 years deep, the most recent figure standing at -$10.5 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 19.19% year-over-year to -$10.5 million; the TTM figure through Mar 2026 stood at -$36.5 million (down 828.88% YoY), while the FY2025 annual figure was -$1.4 million, up 81.91% from the prior year.
- Non Operating Income was -$10.5 million for Q1 2026 at Trulieve Cannabis, down from $626000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $49.0 million in Q4 2022 to a low of -$68.8 million in Q4 2023.
- Historically, Non Operating Income has averaged -$6.6 million across 5 years, with a median of -$12.9 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income surged 753.34% in 2022, then slumped 1294.94% in 2024.
- A 5-year view of Non Operating Income shows it stood at $49.0 million in 2022, then tumbled by 240.48% to -$68.8 million in 2023, then soared by 148.41% to $33.3 million in 2024, then sank by 98.12% to $626000.0 in 2025, then plunged by 1778.12% to -$10.5 million in 2026.
- The last three Non Operating Income figures came in at -$10.5 million (Q1 2026), $626000.0 (Q4 2025), and -$12.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | -10.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.51 Mn |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | -12.94 Mn |
| Jun 30, 2025 | -13.73 Mn |
| Mar 31, 2025 | -13.00 Mn |
| Dec 31, 2024 | 33.31 Mn |
| Sep 30, 2024 | -13.46 Mn |
| Jun 30, 2024 | -1.84 Mn |
| Mar 31, 2024 | -14.15 Mn |
| Dec 31, 2023 | -68.80 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | -16.96 Mn |
| Mar 31, 2023 | -15.99 Mn |
| Dec 31, 2022 | 48.97 Mn |
| Sep 30, 2022 | 448,000.00 |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | -16.17 Mn |
| Dec 31, 2021 | -7.50 Mn |
| Sep 30, 2021 | 89,000.00 |
| Jun 30, 2021 | -6.32 Mn |